

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.58082772 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.58082772 |
| 3 | sleep (GO:0030431) | 4.74937220 |
| 4 | regulation of germinal center formation (GO:0002634) | 4.55376930 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.48491886 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.35397842 |
| 7 | cellular response to interleukin-15 (GO:0071350) | 4.33029959 |
| 8 | microglial cell activation (GO:0001774) | 4.24780037 |
| 9 | response to interleukin-15 (GO:0070672) | 3.92061825 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.91852867 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.89966575 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.89764252 |
| 13 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.81882451 |
| 14 | definitive hemopoiesis (GO:0060216) | 3.81593262 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.79179232 |
| 16 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.67622195 |
| 17 | response to muramyl dipeptide (GO:0032495) | 3.65091689 |
| 18 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.58276758 |
| 19 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.57373901 |
| 20 | negative thymic T cell selection (GO:0045060) | 3.49800445 |
| 21 | negative regulation of interleukin-1 production (GO:0032692) | 3.49729038 |
| 22 | dendritic cell chemotaxis (GO:0002407) | 3.45344611 |
| 23 | lymph vessel development (GO:0001945) | 3.43593371 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.41463572 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.41463572 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.41463572 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.41463572 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 3.41463572 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.41463572 |
| 30 | negative T cell selection (GO:0043383) | 3.39761001 |
| 31 | response to laminar fluid shear stress (GO:0034616) | 3.37965624 |
| 32 | negative regulation of innate immune response (GO:0045824) | 3.37592683 |
| 33 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.36307952 |
| 34 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.35422094 |
| 35 | negative regulation of bone resorption (GO:0045779) | 3.33708406 |
| 36 | positive regulation of cholesterol efflux (GO:0010875) | 3.33546056 |
| 37 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.32077621 |
| 38 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.32077621 |
| 39 | response to gravity (GO:0009629) | 3.30730102 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.27008058 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.26805724 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.24309732 |
| 43 | positive regulation of osteoclast differentiation (GO:0045672) | 3.23117913 |
| 44 | positive regulation of T cell cytokine production (GO:0002726) | 3.22706759 |
| 45 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.19928696 |
| 46 | negative regulation of lipid storage (GO:0010888) | 3.16958709 |
| 47 | regulation of memory T cell differentiation (GO:0043380) | 3.16198080 |
| 48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.11503745 |
| 49 | mast cell activation (GO:0045576) | 3.07747318 |
| 50 | positive regulation of defense response to virus by host (GO:0002230) | 3.05040312 |
| 51 | lymph node development (GO:0048535) | 3.03122803 |
| 52 | positive regulation of cholesterol transport (GO:0032376) | 3.02982416 |
| 53 | positive regulation of sterol transport (GO:0032373) | 3.02982416 |
| 54 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 3.02099185 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 3.01875522 |
| 56 | dendritic cell migration (GO:0036336) | 3.01522441 |
| 57 | regulation of cellular extravasation (GO:0002691) | 3.00686185 |
| 58 | positive regulation of prostaglandin secretion (GO:0032308) | 2.98252446 |
| 59 | macrophage activation (GO:0042116) | 2.97605623 |
| 60 | cellular extravasation (GO:0045123) | 2.97139912 |
| 61 | regulation of chronic inflammatory response (GO:0002676) | 2.96708379 |
| 62 | neutrophil activation involved in immune response (GO:0002283) | 2.95897821 |
| 63 | regulation of T cell mediated immunity (GO:0002709) | 2.95797358 |
| 64 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.95547996 |
| 65 | negative regulation of protein autophosphorylation (GO:0031953) | 2.95271603 |
| 66 | positive regulation of heat generation (GO:0031652) | 2.94036552 |
| 67 | endothelium development (GO:0003158) | 2.94006233 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93926462 |
| 69 | regulation of monocyte differentiation (GO:0045655) | 2.93873985 |
| 70 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.93753804 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.93159848 |
| 72 | positive regulation of T cell mediated immunity (GO:0002711) | 2.88577736 |
| 73 | response to progesterone (GO:0032570) | 2.88488942 |
| 74 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.88419232 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 2.87742837 |
| 76 | regulation of defense response to virus by host (GO:0050691) | 2.86886191 |
| 77 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.86808123 |
| 78 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.86801351 |
| 79 | germ cell migration (GO:0008354) | 2.85850325 |
| 80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84531407 |
| 81 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.84278979 |
| 82 | blood vessel maturation (GO:0001955) | 2.82142162 |
| 83 | alpha-beta T cell differentiation (GO:0046632) | 2.81185318 |
| 84 | RNA destabilization (GO:0050779) | 2.79940036 |
| 85 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.79217265 |
| 86 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.79217265 |
| 87 | interferon-gamma production (GO:0032609) | 2.78904520 |
| 88 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.76746091 |
| 89 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.76609752 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76509416 |
| 91 | regulation of cell killing (GO:0031341) | 2.76059518 |
| 92 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.75610422 |
| 93 | regulation of T-helper 1 type immune response (GO:0002825) | 2.74084000 |
| 94 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74072238 |
| 95 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.71954890 |
| 96 | negative regulation of T cell apoptotic process (GO:0070233) | 2.68519308 |
| 97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.66849915 |
| 98 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66828017 |
| 99 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.66213281 |
| 100 | positive regulation of mRNA catabolic process (GO:0061014) | 2.65926492 |
| 101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.65159035 |
| 102 | macrophage activation involved in immune response (GO:0002281) | 2.63715654 |
| 103 | negative regulation of granulocyte differentiation (GO:0030853) | 2.62235353 |
| 104 | regulation of T cell cytokine production (GO:0002724) | 2.61814870 |
| 105 | negative regulation of bone remodeling (GO:0046851) | 2.61391765 |
| 106 | surfactant homeostasis (GO:0043129) | 2.59981198 |
| 107 | alpha-beta T cell activation (GO:0046631) | 2.59968531 |
| 108 | B cell homeostasis (GO:0001782) | 2.58498113 |
| 109 | positive regulation of T cell differentiation (GO:0045582) | 2.57612255 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.52711114 |
| 111 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.52711114 |
| 112 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.52189142 |
| 113 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.51799362 |
| 114 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.49450222 |
| 115 | T-helper cell differentiation (GO:0042093) | 2.49450222 |
| 116 | monocyte chemotaxis (GO:0002548) | 2.47905803 |
| 117 | lymphangiogenesis (GO:0001946) | 2.46960634 |
| 118 | cellular response to fluid shear stress (GO:0071498) | 2.46555345 |
| 119 | germinal center formation (GO:0002467) | 2.45682024 |
| 120 | tolerance induction (GO:0002507) | 2.45446503 |
| 121 | neutrophil activation (GO:0042119) | 2.43201391 |
| 122 | radial glial cell differentiation (GO:0060019) | 2.42308115 |
| 123 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.42064964 |
| 124 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.40825526 |
| 125 | response to fluid shear stress (GO:0034405) | 2.39105119 |
| 126 | positive regulation of antigen processing and presentation (GO:0002579) | 2.38533184 |
| 127 | T-helper 1 type immune response (GO:0042088) | 2.38169662 |
| 128 | positive regulation of chemokine secretion (GO:0090197) | 2.38159858 |
| 129 | response to peptidoglycan (GO:0032494) | 2.37661367 |
| 130 | cellular response to antibiotic (GO:0071236) | 2.37656863 |
| 131 | hemidesmosome assembly (GO:0031581) | 2.37045272 |
| 132 | response to host immune response (GO:0052572) | 2.36223610 |
| 133 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.36223610 |
| 134 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.36220319 |
| 135 | myeloid dendritic cell activation (GO:0001773) | 2.35108161 |
| 136 | atrioventricular valve morphogenesis (GO:0003181) | 2.34515692 |
| 137 | SMAD protein signal transduction (GO:0060395) | 2.34414655 |
| 138 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.33772526 |
| 139 | immunoglobulin mediated immune response (GO:0016064) | 2.32711563 |
| 140 | wound healing, spreading of cells (GO:0044319) | 2.32476871 |
| 141 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.32212499 |
| 142 | monocyte differentiation (GO:0030224) | 2.30775013 |
| 143 | Notch receptor processing (GO:0007220) | 2.29972632 |
| 144 | myeloid dendritic cell differentiation (GO:0043011) | 2.28761480 |
| 145 | myeloid leukocyte activation (GO:0002274) | 2.26254783 |
| 146 | regulation of mRNA catabolic process (GO:0061013) | 2.23616275 |
| 147 | negative regulation of inclusion body assembly (GO:0090084) | 2.23610417 |
| 148 | negative regulation of interleukin-8 production (GO:0032717) | 2.22544143 |
| 149 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.22151119 |
| 150 | myeloid cell activation involved in immune response (GO:0002275) | 2.21637167 |
| 151 | granulocyte activation (GO:0036230) | 2.21332566 |
| 152 | positive regulation of astrocyte differentiation (GO:0048711) | 2.19446020 |
| 153 | mature B cell differentiation involved in immune response (GO:0002313) | 2.18871612 |
| 154 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.18707174 |
| 155 | response to host (GO:0075136) | 2.18707174 |
| 156 | response to host defenses (GO:0052200) | 2.18707174 |
| 157 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.18443133 |
| 158 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.18232153 |
| 159 | regulation of antigen processing and presentation (GO:0002577) | 2.17021732 |
| 160 | wound healing, spreading of epidermal cells (GO:0035313) | 2.16516338 |
| 161 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.16306972 |
| 162 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.16084077 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.16006446 |
| 164 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.15994443 |
| 165 | cellular response to calcium ion (GO:0071277) | 2.15926924 |
| 166 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.15827621 |
| 167 | gland morphogenesis (GO:0022612) | 2.13565898 |
| 168 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.12225868 |
| 169 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.12225868 |
| 170 | T cell differentiation involved in immune response (GO:0002292) | 2.12225868 |
| 171 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.11674087 |
| 172 | negative regulation of interleukin-6 production (GO:0032715) | 2.11655587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.89803937 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.87605074 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.38742224 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.70070333 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11218214 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00756216 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75168954 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.47674550 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41243080 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36022017 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31847597 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.28683426 |
| 13 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.26605454 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24381513 |
| 15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.16446205 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10363708 |
| 17 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.09088374 |
| 18 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.09088374 |
| 19 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.09088374 |
| 20 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.06762787 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05583893 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.02504205 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98108381 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.96870266 |
| 25 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.93093981 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92336515 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.90027879 |
| 28 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.87583727 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80575639 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.74010748 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.72209003 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71636515 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71616993 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64556323 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.61999484 |
| 36 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59196508 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58289963 |
| 38 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56989587 |
| 39 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56534204 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55386296 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.55073994 |
| 42 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.52744048 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52054068 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49417191 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48483768 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48018573 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38863750 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38598022 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38262356 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37976081 |
| 51 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37095995 |
| 52 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.33953590 |
| 53 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32436646 |
| 54 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31699078 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31132100 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28074848 |
| 57 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26852578 |
| 58 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.26852578 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26767113 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26017670 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24034458 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23046508 |
| 63 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22904792 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21584969 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20230182 |
| 66 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16957794 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14717387 |
| 68 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13359852 |
| 69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13255170 |
| 70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12808741 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.11439250 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10242844 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09994618 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09218056 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.09010538 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08862119 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08354643 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07819142 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06466823 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03472543 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 1.03374185 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03303200 |
| 83 | * MAF_26560356_Chip-Seq_TH1_Human | 1.03244028 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03185972 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03007506 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02240106 |
| 87 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00358206 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98842214 |
| 89 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98195180 |
| 90 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97993306 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97959105 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97672930 |
| 93 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96697988 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96166770 |
| 95 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.95310192 |
| 96 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94557523 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93009644 |
| 98 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92798326 |
| 99 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92798326 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90871128 |
| 101 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90022782 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89715470 |
| 103 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89498193 |
| 104 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89438171 |
| 105 | MYB_26560356_Chip-Seq_TH1_Human | 0.89027951 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88504776 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88255010 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88216072 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87086335 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87021848 |
| 111 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86072707 |
| 112 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86031132 |
| 113 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85842912 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85716144 |
| 115 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84270914 |
| 116 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83090224 |
| 117 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82644523 |
| 118 | * P300_27268052_Chip-Seq_Bcells_Human | 0.82346635 |
| 119 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82321898 |
| 120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81531376 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81340854 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 0.80932862 |
| 123 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80804427 |
| 124 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.80465344 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80224262 |
| 126 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.79183443 |
| 127 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.79063164 |
| 128 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77774547 |
| 129 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77615013 |
| 130 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.77475236 |
| 131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.77363730 |
| 132 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77362546 |
| 133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77341766 |
| 134 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76748690 |
| 135 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76395453 |
| 136 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75939686 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75602772 |
| 138 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.75447852 |
| 139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75025066 |
| 140 | MYC_22102868_ChIP-Seq_BL_Human | 0.72760085 |
| 141 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.70812658 |
| 142 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.70550442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 3.31039790 |
| 2 | * MP0003724_increased_susceptibility_to | 2.84717471 |
| 3 | MP0010368_abnormal_lymphatic_system | 2.72706979 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 2.53572649 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.50925424 |
| 6 | MP0009278_abnormal_bone_marrow | 2.45513955 |
| 7 | MP0001851_eye_inflammation | 2.41153942 |
| 8 | MP0002009_preneoplasia | 2.31637615 |
| 9 | MP0003436_decreased_susceptibility_to | 2.31167647 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.30310951 |
| 11 | MP0003303_peritoneal_inflammation | 2.22328453 |
| 12 | * MP0002419_abnormal_innate_immunity | 2.17650754 |
| 13 | MP0001790_abnormal_immune_system | 2.09269917 |
| 14 | MP0005387_immune_system_phenotype | 2.09269917 |
| 15 | * MP0003828_pulmonary_edema | 2.05553871 |
| 16 | * MP0005000_abnormal_immune_tolerance | 2.03812378 |
| 17 | MP0001853_heart_inflammation | 2.02066822 |
| 18 | MP0004381_abnormal_hair_follicle | 2.01349559 |
| 19 | MP0000383_abnormal_hair_follicle | 1.93255276 |
| 20 | MP0009785_altered_susceptibility_to | 1.89484554 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.89038845 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.87299529 |
| 23 | MP0005671_abnormal_response_to | 1.86702032 |
| 24 | MP0001800_abnormal_humoral_immune | 1.83927772 |
| 25 | MP0000465_gastrointestinal_hemorrhage | 1.81623278 |
| 26 | MP0000685_abnormal_immune_system | 1.77379120 |
| 27 | * MP0002723_abnormal_immune_serum | 1.77378320 |
| 28 | MP0003279_aneurysm | 1.76431454 |
| 29 | MP0004947_skin_inflammation | 1.76235064 |
| 30 | * MP0002405_respiratory_system_inflammati | 1.75209652 |
| 31 | MP0005025_abnormal_response_to | 1.73228260 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.71217985 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.67984233 |
| 34 | MP0004510_myositis | 1.67175629 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.62165681 |
| 36 | MP0000343_altered_response_to | 1.61641252 |
| 37 | MP0001819_abnormal_immune_cell | 1.59893676 |
| 38 | MP0002722_abnormal_immune_system | 1.53250523 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.53202240 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.53202240 |
| 41 | MP0001873_stomach_inflammation | 1.52871546 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.51943111 |
| 43 | * MP0001533_abnormal_skeleton_physiology | 1.50072790 |
| 44 | MP0006082_CNS_inflammation | 1.47503687 |
| 45 | MP0003866_abnormal_defecation | 1.47353137 |
| 46 | MP0004883_abnormal_blood_vessel | 1.45217512 |
| 47 | MP0003075_altered_response_to | 1.44872263 |
| 48 | MP0002933_joint_inflammation | 1.44578327 |
| 49 | MP0005164_abnormal_response_to | 1.43652759 |
| 50 | MP0003943_abnormal_hepatobiliary_system | 1.43435109 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.39564574 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.38653645 |
| 53 | MP0002060_abnormal_skin_morphology | 1.38382971 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.37610012 |
| 55 | MP0010678_abnormal_skin_adnexa | 1.37509864 |
| 56 | MP0003448_altered_tumor_morphology | 1.36863352 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.35879672 |
| 58 | MP0004272_abnormal_basement_membrane | 1.33675254 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.33531977 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.31667078 |
| 61 | MP0005409_darkened_coat_color | 1.31141285 |
| 62 | MP0006054_spinal_hemorrhage | 1.29275322 |
| 63 | MP0009840_abnormal_foam_cell | 1.28570448 |
| 64 | MP0003136_yellow_coat_color | 1.27149842 |
| 65 | MP0000767_abnormal_smooth_muscle | 1.22563299 |
| 66 | MP0002006_tumorigenesis | 1.22380375 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.21709977 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.21224059 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.18830852 |
| 70 | MP0002132_abnormal_respiratory_system | 1.17961992 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.17823819 |
| 72 | * MP0001845_abnormal_inflammatory_respons | 1.17065407 |
| 73 | MP0000249_abnormal_blood_vessel | 1.16524537 |
| 74 | MP0005165_increased_susceptibility_to | 1.16141643 |
| 75 | MP0009764_decreased_sensitivity_to | 1.15184368 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.13508618 |
| 77 | MP0003941_abnormal_skin_development | 1.12155062 |
| 78 | MP0003195_calcinosis | 1.10905102 |
| 79 | MP0002876_abnormal_thyroid_physiology | 1.07634272 |
| 80 | MP0002928_abnormal_bile_duct | 1.07067243 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 1.06215908 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 1.06020352 |
| 83 | * MP0005390_skeleton_phenotype | 1.05273401 |
| 84 | MP0005023_abnormal_wound_healing | 1.05165688 |
| 85 | MP0003252_abnormal_bile_duct | 1.03681764 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 1.03419894 |
| 87 | MP0001216_abnormal_epidermal_layer | 1.02765755 |
| 88 | MP0000716_abnormal_immune_system | 1.01925801 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 1.01073150 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 1.00543837 |
| 91 | MP0004147_increased_porphyrin_level | 1.00214402 |
| 92 | MP0003763_abnormal_thymus_physiology | 1.00049285 |
| 93 | MP0002098_abnormal_vibrissa_morphology | 0.99836445 |
| 94 | MP0001346_abnormal_lacrimal_gland | 0.99747105 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.97383547 |
| 96 | MP0000858_altered_metastatic_potential | 0.97259681 |
| 97 | MP0009379_abnormal_foot_pigmentation | 0.97119502 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 0.95903568 |
| 99 | MP0001958_emphysema | 0.95829826 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.93793709 |
| 101 | MP0001191_abnormal_skin_condition | 0.92325118 |
| 102 | MP0003690_abnormal_glial_cell | 0.92060488 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.91897086 |
| 104 | MP0001542_abnormal_bone_strength | 0.91406771 |
| 105 | MP0002796_impaired_skin_barrier | 0.91026227 |
| 106 | MP0002398_abnormal_bone_marrow | 0.90816215 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.90636393 |
| 108 | MP0004130_abnormal_muscle_cell | 0.89759113 |
| 109 | MP0005310_abnormal_salivary_gland | 0.89121369 |
| 110 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86588816 |
| 111 | MP0005166_decreased_susceptibility_to | 0.86285129 |
| 112 | MP0001919_abnormal_reproductive_system | 0.85683507 |
| 113 | * MP0008469_abnormal_protein_level | 0.85137911 |
| 114 | MP0002429_abnormal_blood_cell | 0.81570794 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.81539106 |
| 116 | MP0003795_abnormal_bone_structure | 0.81035139 |
| 117 | MP0008004_abnormal_stomach_pH | 0.80580214 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.79236682 |
| 119 | MP0003878_abnormal_ear_physiology | 0.79236682 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.77739789 |
| 121 | MP0004484_altered_response_of | 0.74909339 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.73181460 |
| 123 | * MP0009763_increased_sensitivity_to | 0.69238643 |
| 124 | MP0000604_amyloidosis | 0.66151061 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.63875840 |
| 126 | MP0000013_abnormal_adipose_tissue | 0.60396841 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.60016108 |
| 128 | MP0005076_abnormal_cell_differentiation | 0.59382904 |
| 129 | MP0005535_abnormal_body_temperature | 0.59253017 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.59060053 |
| 131 | MP0004885_abnormal_endolymph | 0.56212219 |
| 132 | MP0003183_abnormal_peptide_metabolism | 0.52254184 |
| 133 | MP0003045_fibrosis | 0.52004307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 4.94178141 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.23532497 |
| 3 | T lymphocytopenia (HP:0005403) | 3.99443317 |
| 4 | Abnormality of T cell number (HP:0011839) | 3.91983282 |
| 5 | Prostate neoplasm (HP:0100787) | 3.86773148 |
| 6 | Orchitis (HP:0100796) | 3.78771614 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 3.72544234 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.65308203 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.64930136 |
| 10 | Myositis (HP:0100614) | 3.63262057 |
| 11 | Spontaneous hematomas (HP:0007420) | 3.60823323 |
| 12 | Optic neuritis (HP:0100653) | 3.59785607 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.59785607 |
| 14 | Stomach cancer (HP:0012126) | 3.57876591 |
| 15 | Hematochezia (HP:0002573) | 3.49278865 |
| 16 | Abnormality of T cells (HP:0002843) | 3.48892961 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.46959296 |
| 18 | Abnormality of eosinophils (HP:0001879) | 3.44728871 |
| 19 | Thick nail (HP:0001805) | 3.40844092 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.03243158 |
| 21 | Parakeratosis (HP:0001036) | 3.02257877 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.00435270 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99955820 |
| 24 | Persistence of primary teeth (HP:0006335) | 2.99938606 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97276481 |
| 26 | Premature loss of primary teeth (HP:0006323) | 2.88459779 |
| 27 | Anhidrosis (HP:0000970) | 2.85905106 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.83844904 |
| 29 | Glomerulonephritis (HP:0000099) | 2.79531335 |
| 30 | Thyroiditis (HP:0100646) | 2.78671171 |
| 31 | Eosinophilia (HP:0001880) | 2.76643084 |
| 32 | Pulmonary artery stenosis (HP:0004415) | 2.76066015 |
| 33 | Abnormality of B cell number (HP:0010975) | 2.75025114 |
| 34 | Granulocytopenia (HP:0001913) | 2.74512771 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 2.71909191 |
| 36 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.69401867 |
| 37 | Combined immunodeficiency (HP:0005387) | 2.67663868 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65664674 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65664674 |
| 40 | Gangrene (HP:0100758) | 2.64318154 |
| 41 | Pulmonary fibrosis (HP:0002206) | 2.62979547 |
| 42 | Episodic fever (HP:0001954) | 2.60294714 |
| 43 | Recurrent bronchitis (HP:0002837) | 2.59130644 |
| 44 | Alveolar cell carcinoma (HP:0006519) | 2.48925523 |
| 45 | Vascular tortuosity (HP:0004948) | 2.48501816 |
| 46 | Petechiae (HP:0000967) | 2.48336580 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.47825906 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 2.45571657 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43356772 |
| 50 | Milia (HP:0001056) | 2.42850392 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.40522964 |
| 52 | Abnormality of the nasal mucosa (HP:0000433) | 2.39094968 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.38422973 |
| 54 | Encephalitis (HP:0002383) | 2.37423321 |
| 55 | Arterial tortuosity (HP:0005116) | 2.37012458 |
| 56 | Recurrent skin infections (HP:0001581) | 2.36632354 |
| 57 | Joint swelling (HP:0001386) | 2.36267479 |
| 58 | Increased IgE level (HP:0003212) | 2.35484529 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.33213052 |
| 60 | Chronic otitis media (HP:0000389) | 2.32989696 |
| 61 | Keratitis (HP:0000491) | 2.31982480 |
| 62 | White forelock (HP:0002211) | 2.31802679 |
| 63 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31645034 |
| 64 | Osteolytic defects of the hand bones (HP:0009699) | 2.31645034 |
| 65 | Abnormality of male internal genitalia (HP:0000022) | 2.30904310 |
| 66 | Panhypogammaglobulinemia (HP:0003139) | 2.28125391 |
| 67 | Epistaxis (HP:0000421) | 2.27888835 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27565354 |
| 69 | Obstructive lung disease (HP:0006536) | 2.27565354 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.26370999 |
| 71 | Patchy hypopigmentation of hair (HP:0011365) | 2.26320502 |
| 72 | Cellulitis (HP:0100658) | 2.26150460 |
| 73 | Arterial thrombosis (HP:0004420) | 2.24223335 |
| 74 | Congenital, generalized hypertrichosis (HP:0004540) | 2.23614792 |
| 75 | Colitis (HP:0002583) | 2.22604152 |
| 76 | Increased IgM level (HP:0003496) | 2.22586324 |
| 77 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.21293989 |
| 78 | Pustule (HP:0200039) | 2.21120693 |
| 79 | Aplasia cutis congenita (HP:0001057) | 2.21016682 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.20036703 |
| 81 | Anorexia (HP:0002039) | 2.19953565 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.18651750 |
| 83 | Pulmonary infiltrates (HP:0002113) | 2.18157758 |
| 84 | Mediastinal lymphadenopathy (HP:0100721) | 2.17853047 |
| 85 | Stomatitis (HP:0010280) | 2.17661579 |
| 86 | Conical tooth (HP:0000698) | 2.17426286 |
| 87 | Premature skin wrinkling (HP:0100678) | 2.16996833 |
| 88 | Abnormality of the axillary hair (HP:0100134) | 2.16376282 |
| 89 | Abnormality of secondary sexual hair (HP:0009888) | 2.16376282 |
| 90 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15833392 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15833392 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15833392 |
| 93 | Submucous cleft hard palate (HP:0000176) | 2.15557501 |
| 94 | Growth hormone excess (HP:0000845) | 2.13832466 |
| 95 | Vasculitis (HP:0002633) | 2.13756108 |
| 96 | Hemoptysis (HP:0002105) | 2.13727106 |
| 97 | Axonal loss (HP:0003447) | 2.12734477 |
| 98 | Increased density of long bones (HP:0006392) | 2.12646823 |
| 99 | Abnormality of the prostate (HP:0008775) | 2.10907644 |
| 100 | Dysostosis multiplex (HP:0000943) | 2.10876542 |
| 101 | Increased cerebral lipofuscin (HP:0011813) | 2.10663169 |
| 102 | B lymphocytopenia (HP:0010976) | 2.10447877 |
| 103 | Pancreatitis (HP:0001733) | 2.10355899 |
| 104 | Cheilitis (HP:0100825) | 2.10330410 |
| 105 | Vertigo (HP:0002321) | 2.10249204 |
| 106 | Portal hypertension (HP:0001409) | 2.09464794 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08585578 |
| 108 | Mucopolysacchariduria (HP:0008155) | 2.08585578 |
| 109 | Nephritis (HP:0000123) | 2.08256409 |
| 110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07807693 |
| 111 | Autoimmune hemolytic anemia (HP:0001890) | 2.07159463 |
| 112 | Adactyly (HP:0009776) | 2.07111933 |
| 113 | Pulmonary embolism (HP:0002204) | 2.06815446 |
| 114 | Keratoconjunctivitis (HP:0001096) | 2.04926921 |
| 115 | Amyloidosis (HP:0011034) | 2.03204289 |
| 116 | Agammaglobulinemia (HP:0004432) | 2.03184658 |
| 117 | Ulnar claw (HP:0001178) | 2.01545786 |
| 118 | Periodontitis (HP:0000704) | 2.01314589 |
| 119 | IgM deficiency (HP:0002850) | 2.01015822 |
| 120 | Glomerulopathy (HP:0100820) | 1.99408408 |
| 121 | Plantar hyperkeratosis (HP:0007556) | 1.96861062 |
| 122 | Urticaria (HP:0001025) | 1.96529699 |
| 123 | Myocardial infarction (HP:0001658) | 1.96426034 |
| 124 | Lip pit (HP:0100267) | 1.95808869 |
| 125 | Recurrent viral infections (HP:0004429) | 1.95559518 |
| 126 | Congenital stationary night blindness (HP:0007642) | 1.95372704 |
| 127 | Polyneuropathy (HP:0001271) | 1.94254667 |
| 128 | Clumsiness (HP:0002312) | 1.94208240 |
| 129 | Papilloma (HP:0012740) | 1.93676716 |
| 130 | Verrucae (HP:0200043) | 1.93676716 |
| 131 | Gastrointestinal inflammation (HP:0004386) | 1.93513217 |
| 132 | Acanthosis nigricans (HP:0000956) | 1.92452999 |
| 133 | Asymmetric septal hypertrophy (HP:0001670) | 1.91824102 |
| 134 | Xerostomia (HP:0000217) | 1.91592416 |
| 135 | Atrophic scars (HP:0001075) | 1.91582456 |
| 136 | Polycythemia (HP:0001901) | 1.90063487 |
| 137 | Onycholysis (HP:0001806) | 1.89967114 |
| 138 | Hypergammaglobulinemia (HP:0010702) | 1.89013325 |
| 139 | Chronic diarrhea (HP:0002028) | 1.88657261 |
| 140 | Chest pain (HP:0100749) | 1.87531562 |
| 141 | Joint stiffness (HP:0001387) | 1.87416354 |
| 142 | Abnormality of the pericardium (HP:0001697) | 1.87344753 |
| 143 | Abnormality of the hepatic vasculature (HP:0006707) | 1.86825975 |
| 144 | Joint hemorrhage (HP:0005261) | 1.86286599 |
| 145 | Leukocytosis (HP:0001974) | 1.86276674 |
| 146 | Alopecia of scalp (HP:0002293) | 1.85912462 |
| 147 | Progressive visual loss (HP:0000529) | 1.85184741 |
| 148 | Esophageal varix (HP:0002040) | 1.84948540 |
| 149 | Absent hand (HP:0004050) | 1.83071719 |
| 150 | Hypotrichosis (HP:0001006) | 1.80884016 |
| 151 | Purpura (HP:0000979) | 1.80011700 |
| 152 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78458469 |
| 153 | Ectropion (HP:0000656) | 1.78458434 |
| 154 | Upper limb muscle weakness (HP:0003484) | 1.76303452 |
| 155 | Gingival bleeding (HP:0000225) | 1.74916604 |
| 156 | Spondylolisthesis (HP:0003302) | 1.74548380 |
| 157 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.72281128 |
| 158 | Meningitis (HP:0001287) | 1.71870437 |
| 159 | Gingivitis (HP:0000230) | 1.71024810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 6.25278322 |
| 2 | TIE1 | 4.18927153 |
| 3 | GRK6 | 3.74050244 |
| 4 | TGFBR2 | 3.71015079 |
| 5 | MAP3K14 | 2.75821042 |
| 6 | MAPKAPK5 | 2.32058821 |
| 7 | KDR | 2.30975639 |
| 8 | TESK2 | 2.20975548 |
| 9 | EPHB1 | 2.13031114 |
| 10 | IKBKB | 2.10391124 |
| 11 | GRK7 | 1.90248205 |
| 12 | IRAK3 | 1.84139010 |
| 13 | TEC | 1.78693937 |
| 14 | TYK2 | 1.77289925 |
| 15 | MAP3K13 | 1.77146330 |
| 16 | TLK1 | 1.74000623 |
| 17 | MST4 | 1.73165926 |
| 18 | VRK1 | 1.71035195 |
| 19 | IKBKE | 1.69506452 |
| 20 | IRAK4 | 1.66478616 |
| 21 | TBK1 | 1.59613792 |
| 22 | MAP3K3 | 1.57666352 |
| 23 | TXK | 1.56434875 |
| 24 | NLK | 1.53274986 |
| 25 | TRPM7 | 1.51946116 |
| 26 | STK10 | 1.44154232 |
| 27 | * MAP2K2 | 1.43788595 |
| 28 | BLK | 1.40018171 |
| 29 | MAP4K1 | 1.37394670 |
| 30 | PIM2 | 1.36396806 |
| 31 | CHUK | 1.31724109 |
| 32 | MAPK7 | 1.31078137 |
| 33 | BMPR1B | 1.28770225 |
| 34 | KIT | 1.25074582 |
| 35 | INSRR | 1.22722309 |
| 36 | TSSK6 | 1.13921806 |
| 37 | ADRBK2 | 1.13340678 |
| 38 | IRAK1 | 1.08869674 |
| 39 | ITK | 1.08416610 |
| 40 | GRK1 | 1.06637188 |
| 41 | TGFBR1 | 1.05144851 |
| 42 | JAK3 | 1.04201687 |
| 43 | BTK | 1.02993336 |
| 44 | EPHA3 | 1.01614405 |
| 45 | JAK1 | 0.96764825 |
| 46 | EPHA2 | 0.95819831 |
| 47 | TNK2 | 0.94431285 |
| 48 | CLK1 | 0.93602387 |
| 49 | CSK | 0.91985978 |
| 50 | MAP2K3 | 0.91021136 |
| 51 | ZAP70 | 0.85647757 |
| 52 | GSK3A | 0.85059043 |
| 53 | HIPK2 | 0.84703435 |
| 54 | MAPK4 | 0.84643002 |
| 55 | CSF1R | 0.84342278 |
| 56 | CDK3 | 0.84191849 |
| 57 | MAP3K7 | 0.83312940 |
| 58 | MAP4K2 | 0.83229128 |
| 59 | MAPKAPK2 | 0.80047609 |
| 60 | MOS | 0.73018781 |
| 61 | HCK | 0.69347628 |
| 62 | MATK | 0.68480342 |
| 63 | DMPK | 0.67667706 |
| 64 | PRKCQ | 0.67332127 |
| 65 | RPS6KA6 | 0.67331267 |
| 66 | LCK | 0.65310570 |
| 67 | BMPR2 | 0.64759422 |
| 68 | BCKDK | 0.63901332 |
| 69 | RPS6KA5 | 0.63858147 |
| 70 | RPS6KL1 | 0.63130072 |
| 71 | RPS6KC1 | 0.63130072 |
| 72 | PAK2 | 0.62779301 |
| 73 | MAP3K12 | 0.62075568 |
| 74 | TAOK3 | 0.61492117 |
| 75 | MAP3K1 | 0.60439777 |
| 76 | CDC42BPA | 0.59420578 |
| 77 | NEK6 | 0.59316913 |
| 78 | RPS6KA1 | 0.57789055 |
| 79 | CDK8 | 0.57109185 |
| 80 | NUAK1 | 0.56521548 |
| 81 | MAPK12 | 0.56362787 |
| 82 | PRKD2 | 0.56232771 |
| 83 | MYLK | 0.55705011 |
| 84 | MAPKAPK3 | 0.54598462 |
| 85 | MARK3 | 0.54487261 |
| 86 | EIF2AK2 | 0.53735367 |
| 87 | PIM1 | 0.52542990 |
| 88 | MAP3K11 | 0.52488497 |
| 89 | PINK1 | 0.51491462 |
| 90 | DAPK2 | 0.51435162 |
| 91 | RPS6KA2 | 0.50243272 |
| 92 | PTK2B | 0.49970122 |
| 93 | PDK2 | 0.49841229 |
| 94 | FGFR3 | 0.49730619 |
| 95 | PRKAA2 | 0.49095040 |
| 96 | GRK5 | 0.49031121 |
| 97 | FGR | 0.48862162 |
| 98 | LYN | 0.48744270 |
| 99 | EPHB2 | 0.48532285 |
| 100 | PDK1 | 0.48530413 |
| 101 | FRK | 0.47421668 |
| 102 | ERN1 | 0.45589613 |
| 103 | CAMKK2 | 0.45545930 |
| 104 | PRKG2 | 0.45323720 |
| 105 | ABL1 | 0.44257855 |
| 106 | MAP2K6 | 0.44249842 |
| 107 | RIPK4 | 0.43797181 |
| 108 | PIK3CA | 0.43482210 |
| 109 | PRKD1 | 0.42975860 |
| 110 | RPS6KB2 | 0.42042376 |
| 111 | WNK4 | 0.41865773 |
| 112 | CAMK1D | 0.41820870 |
| 113 | FES | 0.40489373 |
| 114 | JAK2 | 0.40147693 |
| 115 | MAPK11 | 0.39341961 |
| 116 | ZAK | 0.37466542 |
| 117 | PKN1 | 0.37464746 |
| 118 | SYK | 0.37393353 |
| 119 | PRKCE | 0.36661502 |
| 120 | MUSK | 0.36066296 |
| 121 | IRAK2 | 0.35813545 |
| 122 | IGF1R | 0.35798263 |
| 123 | CAMK1G | 0.35783494 |
| 124 | ADRBK1 | 0.35620816 |
| 125 | SIK3 | 0.35556116 |
| 126 | FGFR4 | 0.35133341 |
| 127 | * MAPK3 | 0.32962038 |
| 128 | FLT3 | 0.31970227 |
| 129 | INSR | 0.31846661 |
| 130 | PIK3CG | 0.31672076 |
| 131 | PRKCD | 0.29482194 |
| 132 | CDK4 | 0.28477871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.78662887 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69985897 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.54436781 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46415468 |
| 5 | Pertussis_Homo sapiens_hsa05133 | 2.10556203 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.08993860 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06237245 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95137793 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90316978 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89953318 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.87506345 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81898752 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80913200 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.79431434 |
| 15 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.71626971 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.66960139 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66674493 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54221982 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52434790 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48453586 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.47089337 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.47010039 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.42592371 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40844096 |
| 25 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.39944308 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39262134 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.35778286 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.34266663 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.28717362 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21203955 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.19853561 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19235725 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.17201666 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.15434053 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12880990 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12551011 |
| 37 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11024612 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10836513 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10377929 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09633940 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.08959624 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.06388911 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03652422 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02071384 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.01729496 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01330213 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.01008168 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00735422 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96766272 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.95780771 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95779344 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95060105 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.94408061 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.92835223 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92275702 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89112445 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.88579273 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.83713744 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83658793 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.83432408 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.83181851 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81763499 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80890727 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80175229 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79257283 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79200618 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76104212 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.75370182 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74577654 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72931053 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.72908018 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72163225 |
| 73 | Pathways in cancer_Homo sapiens_hsa05200 | 0.71066621 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69965847 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68064919 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67976929 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67597425 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.67415425 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66583081 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66554728 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66422821 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66271080 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66128051 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66082583 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.65735252 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.65707428 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64758081 |
| 88 | Phototransduction_Homo sapiens_hsa04744 | 0.64444098 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64391589 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64365545 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64297620 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62870977 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61783589 |
| 94 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61606298 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61395104 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60300863 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.58702685 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58214531 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57162490 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56985914 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55841494 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55437751 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54739631 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53526806 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52823973 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52672571 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51465188 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50485817 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50475262 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.48930766 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48332996 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46979005 |
| 113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46924850 |
| 114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46741144 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46636646 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45397782 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44924746 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44110934 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38599065 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.36319204 |
| 121 | Morphine addiction_Homo sapiens_hsa05032 | 0.33608888 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30648084 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.30575855 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24529285 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24312316 |
| 126 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.21598988 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19070168 |
| 128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18768063 |
| 129 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17286999 |
| 130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16563109 |

